MetLife, Inc is an insurance-life business based in the US. MetLife shares (MET) are listed on the NYSE and all prices are listed in US Dollars.
How to buy shares in MetLife
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MET – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- MET shares summary
- Compare share dealing platforms
- Is MET stock a buy or sell?
- Stock performance over time
- Can I short MET shares?
- Is MET suitable for ethical investing?
- Are MET shares over-valued?
- MetLife's financials
- How volatile are MET shares?
- Does MetLife pay a dividend?
- Have MET shares ever split?
- Other common questions
MetLife stock price (NYSE: MET)Use our graph to track the performance of MET stocks over time.
MetLife shares at a glance
|Latest market close||$66.56|
|52-week range||$34.19 - $67.68|
|50-day moving average||$59.53|
|200-day moving average||$59.61|
|Wall St. target price||$70.82|
|Dividend yield||$1.84 (3.19%)|
|Earnings per share (TTM)||$1.23|
Buy MetLife shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy MetLife stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
MetLife price performance over time
|1 week (2021-07-20)||N/A|
|1 month (2021-07-01)||10.00%|
|3 months (2021-04-30)||4.60%|
|6 months (2021-01-27)||N/A|
|1 year (2020-07-27)||N/A|
|2 years (2019-07-27)||N/A|
|3 years (2018-07-27)||N/A|
|5 years (2016-07-27)||N/A|
Is MetLife under- or over-valued?
Valuing MetLife stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MetLife's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MetLife's P/E ratio
MetLife's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 47x. In other words, MetLife shares trade at around 47x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
MetLife's PEG ratio
MetLife's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0751. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MetLife's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
MetLife's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.9 billion.
The EBITDA is a measure of a MetLife's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$65.1 billion|
|Operating margin TTM||3.83%|
|Gross profit TTM||$20.1 billion|
|Return on assets TTM||0.21%|
|Return on equity TTM||2.02%|
|Market capitalisation||$51 billion|
TTM: trailing 12 months
Shorting MetLife shares
There are currently 12.9 million MetLife shares held short by investors – that's known as MetLife's "short interest". This figure is 25.8% down from 17.3 million last month.
There are a few different ways that this level of interest in shorting MetLife shares can be evaluated.
MetLife's "short interest ratio" (SIR)
MetLife's "short interest ratio" (SIR) is the quantity of MetLife shares currently shorted divided by the average quantity of MetLife shares traded daily (recently around 6.0 million). MetLife's SIR currently stands at 2.16. In other words for every 100,000 MetLife shares traded daily on the market, roughly 2160 shares are currently held short.
However MetLife's short interest can also be evaluated against the total number of MetLife shares, or, against the total number of tradable MetLife shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case MetLife's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 MetLife shares in existence, roughly 10 shares are currently held short) or 0.0174% of the tradable shares (for every 100,000 tradable MetLife shares, roughly 17 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against MetLife.
Find out more about how you can short MetLife stock.
MetLife's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like MetLife.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
MetLife's total ESG risk score
Total ESG risk: 18.05
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and MetLife's overall score of 18.05 (as at 12/31/2018) is excellent – landing it in it in the 17th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like MetLife is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
MetLife's environmental score
Environmental score: 0.62/100
MetLife's environmental score of 0.62 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that MetLife is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
MetLife's social score
Social score: 7.35/100
MetLife's social score of 7.35 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that MetLife is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
MetLife's governance score
Governance score: 9.83/100
MetLife's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that MetLife is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
MetLife's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. MetLife scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that MetLife has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||18.05|
|Total ESG percentile||16.56|
|Environmental score percentile||2|
|Social score percentile||2|
|Governance score percentile||2|
|Level of controversy||2|
MetLife share dividends
Dividend payout ratio: 31.54% of net profits
Recently MetLife has paid out, on average, around 31.54% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.33% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), MetLife shareholders could enjoy a 3.33% return on their shares, in the form of dividend payments. In MetLife's case, that would currently equate to about $1.84 per share.
While MetLife's payout ratio might seem fairly standard, it's worth remembering that MetLife may be investing much of the rest of its net profits in future growth.
MetLife's most recent dividend payout was on 13 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 8 August 2021 (the "ex-dividend date").
Have MetLife's shares ever split?
MetLife's shares were split on a 1122:1000 basis on 6 August 2017. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1122 shares. This wouldn't directly have changed the overall worth of your MetLife shares – just the quantity. However, indirectly, the new 10.9% lower share price could have impacted the market appetite for MetLife shares which in turn could have impacted MetLife's share price.
MetLife share price volatility
Over the last 12 months, MetLife's shares have ranged in value from as little as $34.1923 up to $67.68. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MetLife's is 1.315. This would suggest that MetLife's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
MetLife, Inc. , a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U. S. ; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives.
Stocks similar to MetLife
MetLife in the news
MET September 10th Options Begin Trading
MetLife (MET) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
What's in the Cards for MetLife's (MET) Earnings in Q2?
Frequently asked questionsWhat percentage of MetLife is owned by insiders or institutions?
Currently 15.368% of MetLife shares are held by insiders and 78.445% by institutions. When does the fiscal year end for MetLife?
MetLife's fiscal year ends in December. Where is MetLife based?
MetLife's address is: 200 Park Avenue, New York, NY, United States, 10166-0188 What is MetLife's ISIN number?
MetLife's international securities identification number is: US59156R1086 What is MetLife's CUSIP number?
MetLife's Committee on Uniform Securities Identification Procedures number is: 59156R108
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert